TYK Medicines, Inc. Class H (2410) Income Statement

Last quarter (Q2 2024), TYK Medicines, Inc. Class H's total revenue was ¥0.00, a decrease of ― from previous quarter. In Q2, TYK Medicines, Inc. Class H's net income was ¥-111.53M. See TYK Medicines, Inc. Class H’s key income statements, including revenue, expenses, profit, and income.